The world has changed. In the wake of Covid-19, and the global recession it has caused, business leaders, innovators, entrepreneurs, and investors are all girding for a long period of extremely challenging conditions in the global market. How can startups and innovators of all stripes survive in such conditions? Many are not prepared. Read more...
Read MoreThe new realities of a Covid world where travel restrictions are the norm have forced a hard reckoning on the Israel tech sector. As if that is not enough, the country’s legions of venture capitalists and startup founders are faced with tensions between the US and China that may not be disappearing any time soon. Read more on...
Read MoreIn recent posts on its official blog, Israeli-based behavioral biometrics company BioCatch establishes the difference between static and behavioral biometrics modalities, and makes the case for the advantages of the latter in today’s rapidly evolving digital landscape. Read...
Read MoreReal-world results show users prefer to wait on COVID-19 vaccine dose, refer to a physician for guidance on timing, according to a new survey from Medisafe, a digital therapeutics platform that supports users with advanced medication management. The survey reveals sixty-five percent of patients say they will wait to receive the forthcoming COVID-19 vaccine even if it becomes available before the end of 2020. The majority of survey participants cited uncertainty in its overall effectiveness and potential side-effects from the vaccine as top reasons for the delay. Read...
Read MoreLocusview’s easy-to-use digital construction mobile application (Locusview Mobile) enables field crews to create high accuracy paperless as-constructed records, whilst also providing improved compliance, visibility and traceability. This not only removes manual drawing and data entry but also validates that the data is complete and accurate. Importantly, Locusview’s philosophy of “field crews first” promotes positive take up and improved use in the field. Read more...
Read More
